Česká televize: MLS® and M8 in the effective treatment of post-Covid

18 September 2023 - Therapies -

Not only functional and effective in the recovery of problems related to post-Covid - which affect 4.5 million Europeans annually - but also as a "natural" healing support in wellness centres.

Thanks to the M8 robotic device, MLS® Laser Therapy is at the centre of a report broadcast on the Czech television news. In October, a speech by Dr Martin Plachý will also highlight the advantages of the ASA robotic system. The vice president of the Association of Medical Spas of the Czech Republic, during the International Spa Congress, will present the results of a study conducted on 400 patients and dedicated to the use of MLS® Laser Therapy in post-Covid.

You might also be interested in ...

See all articles

Before and After MLS Laser Therapy
blog - 12/10/2021
Used as a complementary treatment to standard drug therapy, MLS® alleviates acute inflammatory events caused by an excessive production of pro-inflammatory cytokines and favours pulmonary functional...
press - 21/01/2021
After viewing the successful results obtained by Doctor Scott Sigman (an orthopaedic surgeon in Massachusetts) when using MLS® Laser Therapy for a clinical trial to treat interstitial pneumonia...
M6 laser & pain management
news - 21/01/2021
“Following our direct experience, we confirm the conclusions reached in America in relation to the value of MLS® for treating interstitial pneumonia caused by the virus. Its action consists in...
Press - 23/01/2025
Anti-inflammatory, muscle relaxant and effective in rapidly reducing pain, MLS® Laser Therapy is the recommended therapy to successfully treat various muscular diseases.
Press - 23/01/2025
New valuable milestones for MLS® Laser Therapy, which is confirmed as a decisive therapy in pain management.
 Diabetic Peripheral Neuropathic Pain Using MiS MLS Laser
Blog - 23/01/2025
This clinical case highlights the effectiveness of using the MiS laser device on a 67-year-old woman who was diagnosed with type II diabetes mellitus in 2008.